Jefferies lowered the firm’s price target on Scotts Miracle-Gro (SMG) to $71 from $79 and keeps a Buy rating on the shares. With the company’s fiscal Q4 coming to a close next week, the firm reiterates its FY25 estimates and trims its FY26 forecasts, including trimming its gross margin forecast by about 60 points to 32.0%. With the new fiscal year beginning next week and no announcement regarding a final Hawthorne separation, the firm continues to model revenues from that segment and reflects it’s lower-margin profile dragging on FY26 results until a transaction is consummated, the analyst noted.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG:
- ADM, DE, SMG: Corn Disease Hits America’s Heartland, Threatening Crops
- Scotts Miracle-Gro Amends Receivables Agreement with JPMorgan
- 5 Undervalued Small-Cap Stocks to Buy Right Now, 8/27/25
- Scotts Miracle-Gro (SMG) Looks to Exit Cannabis Market as Sales Drop
- Scotts Miracle-Gro made a bet on cannabis, now backing out, WSJ reports